The Department of Pharmacovigilance and Clinical Trials will hold a one-day, hybrid stakeholder engagement session to discuss pharmacovigilance guidelines for Marketing Authorisation Holders (MAHs), as well as guidance on promotional materials, advertisements, and post-market surveillance regulations. Additionally, the session will provide a demonstration on how stakeholders can efficiently utilise the Botswana Medicines Regulatory Authority’s Regulatory Information Management System (BRIMS) to access the department’s services.
This engagement presents an opportunity for the Authority to interact with MAHs and the broader pharmaceutical industry and share with them Botswana’s aspirations to achieve a Maturity Level 3 (ML3) rated regulatory system. Attendees will be briefed on the journey and progress towards ML3, as well as the industry’s responsibilities in helping the country achieve this milestone.
The stakeholder engagement is open to all manufacturers, current or prospective MAHs, distributors/wholesalers, local representatives, pharmaceutical industry associations, and principals.
For those willing to attend the session physically, the details are as follows:
• Date: 8th October 2024
• Venue: Cresta President Hotel, Gaborone
• Time: 0800hours – 1300hours
For those wishing to join virtually, please register by 4th October 2024 using the link below.
Further details regarding the session will be shared directly with confirmed participants. https://forms.gle/dJgz8kuzi5Etq6pe9
For any additional questions or clarifications, please contact: Mr. Lebogang Koitsiwe at lkoitsiwe@bomra.co.bw or 373 1771 or Mr. Nonofo Thapelo at nthapelo@bomra.co.bw or 373 1769.